ZMUni Compliance Centre

Recently, ZMUni Compliance Centre successfully supported Scientis in securing approval for its Cyspera® product in China, a Special Cosmetic product with whitening and freckle-removing claims.   Compared with general cosmetics, Special Cosmetics in China are subject to more stringent regulatory requirements, requiring extensive technical documentation, detailed formulation review, safety assessment, efficacy evaluation, and regulatory compliance review. ZMUni provided end-to-end regulatory support throughout the registration process, including dossier preparation and review, compliance assessment, submission support, and regulatory follow-up.   Leveraging its regulatory expertise and efficient project management, ZMUni supported Scientis in successfully completing the registration process and obtaining approval on the

    On July 10, 2026, China's National Medical Products Administration (NMPA) announced the expansion of the second phase of its personalized cosmetics pilot program. Starting August 1, 2026, eight additional regions - Liaoning, Jiangsu, Anhui, Fujian, Jiangxi, Hubei, Sichuan, and Xinjiang - will be included in the pilot program, with the pilot period running until September 30, 2027.   The personalized cosmetics pilot program was initially launched in 2022, with the first phase covering five regions. In September 2025, NMPA initiated the second phase of the pilot program, expanding the scope to 15 regions and allowing eligible enterprises to

    On April 30, 2026, China's State Administration for Market Regulation (SAMR) and the Standardization Administration of China (SAC) jointly issued GB 26396-2026 Safety Technical Specification for Cleaning Products (the "Standard”), replacing the previous recommended standard GB/T 26396-2011 Technical Specification for Safety of Soaps and Detergents.   The new Standard upgrades cleaning product safety requirements from a recommended national standard to a mandatory national standard and will take effect on May 1, 2027. From this date, cleaning products placed on the Chinese market must comply with the new requirements on ingredients, labeling, and safety documentation.   This article highlights

    On July 7, 2026, China's National Medical Products Administration (NMPA) issued a notice proposing the development of a cosmetic standard for Ethyl Butylacetylaminopropionate.   In China, Ethyl Butylacetylaminopropionate has a dual regulatory identity, as it can be used both as a cosmetic ingredient in daily chemical products and as an active ingredient in mosquito repellent pesticides.   For cosmetic use, Ethyl Butylacetylaminopropionate has been included in the Inventory of Existing Cosmetic Ingredients in China (IECIC) Category I under entry No. 01962. Its approved functions are specified as skin protectant and cleansing agent.

    The Cosmetic Product Information File (PIF) system in Taiwan was introduced in 2019 and gradually implemented through a three-phase rollout. As of July 1, 2026, the PIF requirements have become fully effective for all cosmetic products placed on the Taiwan market.   Under the new requirements, brand owners, manufacturers, and importers must prepare and maintain complete PIF documentation before placing cosmetic products on the market. ZMUni Compliance Centre summarizes the key requirements and frequently asked questions to help businesses better understand their compliance obligations.     What is a Product Information File (PIF)?   A Product Information File

   From July 1 to 7, a total of five new cosmetic ingredients completed notification with China's National Medical Products Administration (NMPA). The technical requirements for all related NCIs have not been publicly disclosed.      S-{8-[(4,4,4-trifluorobutyl)sulfanyl]octyl}(2,3-dihydroxyphenyl)methanethioate (Notification No.2026018)   S-{8-[(4,4,4-trifluorobutyl)sulfanyl]octyl}(2,3-dihydroxyphenyl)methanethioate is a chemically synthesized cosmetic ingredient. Based on efficacy tests and in vitro studies, it can help improve TEWL, skin softness, and hair shine, and may be used as a skin protectant, emollient, and hair conditioning agent.   With regulatory support from ZMUni Compliance Centre, this ingredient completed its NCI notification and entered the public disclosure stage, marking the

This article provides a comprehensive overview of key regulatory developments in the food sector inJune 2026, both in China and internationally. It focuses on updates related to new food ingredients, food additives, health foods, and feed, aiming to offer timely and in-depth regulatory alerts for enterprises engaged in food import and export.    Greater China Food Regulatory Updates 🔘 China Three New Food Updates (June 2026)   In June 2026, the National Health Commission (NHC) released updates on the review status of "Three New Food" substances, covering the acceptance and termination of reviews for new food ingredients, as well as applications

Recently, ZMUni Compliance Centre successfully supported XtalPi Holdings Limited (2228.HK) in securing a U.S. Self-affirmed GRAS determination for Tensotide™, an innovative oral peptide ingredient designed for blood glucose management. Developed through XtalPi's proprietary AI-powered peptide platform PepiX™, Tensotide™ is now cleared for lawful use in foods and dietary supplements in the United States, enabling a significant step forward in its global commercialization pathway.   This milestone represents another key achievement for XtalPi in the consumer health space and highlights ZMUni Compliance Centre's strong capabilities in overseas food regulatory compliance and international market access for novel and innovative ingredients, consistently enabling